NIPH Clinical Trials Search

Clinical impact evaluation of multiplex PCR test for joint infection

Basic Information

Recruitment status	Pending
Health condition(s) or Problem(s) studied	Joint infection
Date of first enrollment	01/05/2026
Target sample size	900
Countries of recruitment
Study type	Observational
Intervention(s)	Addition of multiplex PCR joint infection panel

Outcome(s)

Primary Outcome	antimicrobial use (days of therapy, type), hospitalization rate, length of stay
Secondary Outcome	cost, recurrent joint infection, long-term antimicrobial use, time to appropriate antimicrobial treatment

Key inclusion & exclusion criteria

Age minimum	Not applicable
Age maximum	Not applicable
Gender	Both
Include criteria	Patients with suspected joint infection for which joint fluid or synovial fluid has been obtained with gram stain and culture.
Exclude criteria	Lack of residual synovial fluid (0.2ml) to run multipmex PCR test